Information Provided By:
Fly News Breaks for September 8, 2015
SNY
Sep 8, 2015 | 07:25 EDT
UBS analyst Alexandra Hauber upgraded Sanofi to Buy saying the launch of Praluent is being underappreciated by investors. Hauber believes Praluent sales beats starting in 2016 should "result in fast escalation of Praluent peak sales expectations." The analyst raised her price target for Sanofi to EUR 111 from EUR 100.
News For SNY From the Last 2 Days
There are no results for your query SNY
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.